provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
Pombiliti Coupon - Pombiliti 105mg vial

Pombiliti

cipaglucosidase alfa
Used for Lysosomal Storage Disease
Used for Lysosomal Storage Disease

Pombiliti (cipaglucosidase alfa) is an enzyme replacement therapy that treats Pompe disease in adults. It's given as an infusion once every 2 weeks by a healthcare provider. You need to take Opfolda (miglustat) an hour before each infusion; this is an oral medication that helps Pombiliti (cipaglucosidase alfa) work better. Some common side effects of this combination treatment include headache and diarrhea. The Pombiliti (cipaglucosidase alfa) infusion itself can put you at risk throat swelling, hives, and other serious infusion-related reactions.

Reviewed by:
reviewer
Robert Chad Hakim, PharmD, BCCCP
reviewer
Kristianne Hannemann, PharmD
Last reviewed on January 18, 2024
BasicsFAQsAlternativesImagesReferencesPricesMedicare
basics-icon

What is Pombiliti (cipaglucosidase alfa)?

What is Pombiliti (cipaglucosidase alfa) used for?

How Pombiliti (cipaglucosidase alfa) works

People who have Pompe disease don't have enough of an enzyme (protein) called acid alpha-glucosidase (GAA). This enzyme typically helps convert glycogen stored in cells into sugars to be used for energy. Without enough GAA, glycogen builds up in the cells and can cause problems, such as muscle weakness.

Pombiliti (cipaglucosidase alfa-atga) is an enzyme replacement therapy (ERT) used to replace GAA in people with Pompe disease. It's given along with an enzyme stabilizer called Opfolda (miglustat) that prevents Pombiliti from breaking down too quickly in the body.

Drug Facts

Common BrandsPombiliti
Drug ClassEnzyme replacement therapy
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
faqs

Frequently asked questions about Pombiliti (cipaglucosidase alfa)

Why is Pombiliti (cipaglucosidase alfa) given with Opfolda (miglustat)?
Opfolda (miglustat) is an enzyme stabilizer. It prevents Pombiliti (cipaglucosidase alfa), an enzyme, from getting broken down too quickly in the body. Opfolda (miglustat) is typically taken 1 hour before Pombiliti (cipaglucosidase alfa). If you miss your dose of Opfolda (miglustat), your provider might ask you to reschedule your Pombiliti (cipaglucosidase alfa) infusion.
How do you administer Pombiliti (cipaglucosidase alfa)?
Pombiliti (cipaglucosidase alfa) is given as a slow infusion through the veins by a healthcare provider at their office or at an infusion center.
How long does a Pombiliti (cipaglucosidase alfa) infusion take?
The typical length of the Pombiliti (cipaglucosidase alfa) infusion is about 4 hours. But it could take longer if you experience infusion-related reactions (e.g., hives, chills, or low blood pressure) because your provider might need to stop or slow the infusion. They might also give you medications like acetaminophen (Tylenol), diphenhydramine (Benadryl), or a steroid, to help relieve these infusion-related symptoms. Let your care team know right away if you experience any reactions during the infusion.
How long do I have to take Pombiliti (cipaglucosidase alfa)?
Since Pompe disease is a genetic condition, you'll need to receive treatment for your entire life. Your provider will likely ask you to continue Pombiliti (cipaglucosidase alfa) as long as it's helping your condition and you're not having severe side effects. If you have questions about treatment options for Pompe disease, talk with your provider.
Is Pombiliti (cipaglucosidase alfa) safe during pregnancy?
No, Pombiliti (cipaglucosidase alfa) and Opfolda (miglustat) must be avoided during pregnancy. Studies suggest this combination can cause severe harm to babies if taken by mothers during pregnancy. If you're able to become pregnant, your provider will ask you to take a pregnancy test before starting treatment. In addition, you should use birth control during and for at least 2 months after the last dose of Opfolda and Pombiliti. Talk to your provider about your options if you're thinking about getting pregnant or are pregnant.
What are some side effects of Pombiliti (cipaglucosidase alfa)?
Headache and diarrhea were the most common side effects reported in people taking Pombiliti (cipaglucosidase alfa) with Opfolda (miglustat). And Pombiliti (cipaglucosidase alfa) infusions can also cause infusion-related side effects, such as muscle pain or spasms, tiredness, dizziness, fever, and chills. Some of the more serious side effect of this medication include heart or breathing problems. Talk with your provider about any concerns you have about Pombiliti (cipaglucosidase alfa) side effects.
GoodRxEducationalIcon

How to save using GoodRx

Compare Prices
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
Select your free coupon
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
Show coupon to your pharmacist
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get free couponLearn more
alternatives

What are alternatives to Pombiliti (cipaglucosidase alfa)?

There are a number of medications that your doctor can prescribe in place of Pombiliti (cipaglucosidase alfa). Compare a few possible alternatives below.
Pombiliti (cipaglucosidase alfa)
Used for:
View Prices
Lumizyme (alglucosidase alfa)
Used for:

  • Pompe disease

View Prices
Nexviazyme (avalglucosidase alfa)
Used for:

  • Late-onset Pompe disease (LOPD)

View Prices
images

Pombiliti (cipaglucosidase alfa) images

yellow - POMBILITI 105mg Powder for Injection
This medicine is Yellow Vial.yellow - POMBILITI 105mg Powder for Injection
yellow - POMBILITI 105mg Powder for Injection
This medicine is Yellow Vial.yellow - POMBILITI 105mg Powder for Injection
yellow - POMBILITI 105mg Powder for Injection
This medicine is Yellow Vial.yellow - POMBILITI 105mg Powder for Injection

Get savings updates for Pombiliti (cipaglucosidase alfa)

Receive price alerts, news, and other messages from GoodRx about Pombiliti (cipaglucosidase alfa) and other healthcare topics and relevant savings offers.

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

References

Best studies we found

Amicus Therapeutics US, LLC. (2023). Pombiliti atga- cipaglucosidase alfa-atga injection, powder, lyophilized, for solution [package insert]. DailyMed.

MedlinePlus. (2010). GAA gene.

National Organization for Rare Disorders. (2024). Pompe disease.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
Was this page helpful?

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.